Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 100 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Taher N.

Israel

USD 100 /hr

Prof. Pharm. Sci, Drug Delivery Expert | ORAL,TOPICAL,INJECTABLE, wide experinec in Nanotech) || Analytics, CMC

Profile Summary

Professor of Pharmaceutical Sciences and drug-delivery expert with 30+ years translating nano-enabled therapeutics from bench to clinic. My core work is designing targeted and bi-functional medicines and building practical delivery systems—especially ORAL, TOPICAL, and INJECTABLE (also ocular, intranasal, and inhaled when relevant). Across 12+ ventures, I have helped teams move candidates into clinical-phase studies and secure funding by solving solubility, permeability, and stability barriers and delivering robust, test-ready prototypes. Nanotechnology: PLGA and other polymeric nanoparticles, lipidic/LNP systems, liposomes, nanoemulsions, micelles, sustained-release depots, and penetration enhancers. Analytics: LC–MS/MS, HPLC, dissolution/release testing, DLS particle sizing & PDI, zeta potential, rheology, SEM/TEM, stability-indicating methods, bioanalytical assay development, and validation. Drug design & optimization: medicinal-chemistry strategy (targeted/bi-functional constructs, prodrugs, scaffold selection), PK/PD-informed decisions that increase exposure and therapeutic index. Track record: 65+ peer-reviewed publications, founder/co-founder of 12+ startups (TRIGONE, Elgan Pharma, BNS, NOXON, MEDWELL LAB, IDD Therapeutics), and $21M+ secured across public/private and competitive academic grants. Available remotely for formulation triage, nano-delivery strategy, analytical method setup, and SAB/advisory support.

Subject Matter Expertise

• ☆ Computational Biology
• ☆ R
• ☆ Pharmacy
• ☆ Pharmacy Education
• ☆ Drug Discovery
• ☆ Drug Target Identification
• ☆ Medicinal Chemistry
• ☆ Drug Design
• ☆ Structure-Activity Relationship (SAR) Studies
• ☆ Drug Development
• ☆ Pharmacogenomics
• ☆ Pharmaceutical Manufacturing
• ☆ Pharmaceutical Process Development
• ☆ Small Molecule Manufacturing
• ☆ Dermatology
• ☆ Skin Cancer
• ☆ Ophthalmology
• ☆ Neuro-Ophthalmology
• ☆ Pediatric Medicine
• ☆ Pediatric Gastroenterology
• ☆ Women's Health
• ☆ Breast Cancer
• ☆ Ovarian Cancer
• ☆ Men's Health
• ☆ Prostate Cancer
• ☆ Erectile Dysfunction
• ☆ Oncology
• ☆ Chemotherapy
• ☆ Pediatric Oncology
• ☆ Gastroenterology & Hepatology
• ☆ Colorectal Cancer
• ☆ Pancreatic Cancer
• ☆ Stomach & Esophageal Cancer
• ☆ Crohn's Disease
• ☆ Irritable Bowel Syndrome (IBS)
• ☆ Liver Cancer
• ☆ Endocrinology
• ☆ Diabetes
• ☆ Dentistry
• ☆ Implantology
• ☆ Cardiovascular Disease
• ☆ Cardiovascular Disease Management
• ☆ Pediatric Cardiology
• ☆ Dermatitis
• ☆ Pediatric Endocrinology
• ☆ Autoimmune Disease
• ☆ Lupus
• ☆ Inflammation
• ☆ Cancer Research
• ☆ Cancer Biology
• ☆ Carcinogenesis
• ☆ Neuro-Oncology
• ☆ Pediatric Hematology-Oncology
• ☆ Pharmaceutical Management
• ☆ Drug Delivery Technologies
• ☆ Liposomes
• ☆ Pharmaceutical Technology
• ☆ Metabolism & Metabolic Disease
• ☆ Neonatal Medicine
• ☆ Formulation
• ☆ Pharmaceutical Formulation

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Medical Writing, Non-Medical Regulatory Writing, Technical Writing

Research User Research, Feasibility Study, Scientific and Technical Research

Consulting Operations Consulting, Scientific and Technical Consulting, Regulatory Consulting, Manufacturing Consulting

Data & AI Statistical Analysis, Image Processing, Image Analysis, Data Mining, Data Processing, Data Insights

Product Development Formulation, Recipe Development, Deformulation, Stability/Shelf Life Testing, Product Evaluation, Material Sourcing, Concept Development, Prototyping

Work Experience

Founder/CSO

trigone pharma

January 2022 - Present

The Hebrew University of Jerusalem

January 2007 - Present

Founder/CSO

BIONanoSIM (BNS )

January 2014 - January 2024

Founder/CSO

elgan pharma

January 2018 - January 2023

Education

Pharm (Doctor of Pharmacy)

HEBREW UNIVERCITY

January 1989 - January 2020

Certifications

• Project Management Professional

  Hebrew University

  January 1996 - Present

Publications

JOURNAL ARTICLE

Taher Nassar, Ihab Abd-Elrahman, Noha Khairi, Riki Perlman, Simon Benita, Dina Ben Yehuda (2025). Correction: Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma . Oncogene.

Taher Nassar, Sarin Palakkal, Angèle Cortial, Marina Frušić-Zlotkin, Yoram Soroka, Tomer Tzur, Simon Benita (2023). Effect of cyclosporine A - tempol topical gel for the treatment of alopecia and anti-inflammatory disorders . International Journal of Pharmaceutics.

Taher Nassar, Nikhil Biswas, Aiman Abu Ammar, Marina Frušić-Zlotkin, Naama Adi-Hen, Yonat Lehman-Katabi, Yael Levi-Kalisman, Simon Benita (2021). Biodistribution and efficacy of the anticancer drug, oxaliplatin palmitate acetate, in mice . International Journal of Pharmaceutics.

Taher Nassar, Ihab Abd-Elrahman, Noha Khairi, Riki Perlman, Simon Benita, Dina Ben Yehuda (2021). Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma . Oncogene.